Safety of Deferasirox (Exjade (R)) in Myelodysplastic Syndromes (MDS) and Non-MDS Patients with Transfusional Iron Overload: A Pooled Analysis Focusing On Renal Function Schmid, M., Cappellini, M., Porter, J. B., Greenberg, P. L., Lawniczek, T., Glaser, S., Dong, V., Gattermann, N. AMER SOC HEMATOLOGY. 2009: 702–3

View details for Web of Science ID 000272725802136